Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3

被引:39
作者
Malloy, SI
Altenburg, MK
Knouff, C
Lanningham-Foster, L
Parks, JS
Maeda, N [1 ]
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA
关键词
apolipoprotein E isoforms; atherosclerosis; genetic interaction; lipid metabolism; postprandiol hypercholesterolemia;
D O I
10.1161/01.ATV.0000094963.07902.FB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Increased expression of the low-density lipoprotein receptor (LDLR) is generally considered beneficial for reducing plasma cholesterol and atherosclerosis, and its downregulation has been thought to explain the association between apolipoprotein (apo) E4 and increased risk of coronary heart disease in humans. Methods and Results-Contrary to this hypothesis, doubling Ldlr expression caused severe atherosclerosis with marked accumulation of cholesterol-rich, apoE-poor remnants in mice with human apoE4, but not apoE3, when the animals were fed a Western-type diet. The increased Ldlr expression enhanced in vivo clearance of exogenously introduced remnants in mice with apoE4 only when the remnants were already enriched with apoE4. The rates of nascent lipoprotein production were the same. The adverse effects of increased LDLR suggest a possibility that the receptor can trap apoE4, reducing its availability for the transfer to nascent lipoproteins needed for their rapid clearance, thereby increasing the production of apoE-poor remnants that are slowly cleared. The lower affinity for the LDLR of apoE3 compared with apoE4 could then explain why increased receptor expression had no adverse effects with apoE3. Conclusions-Our results emphasize the occurrence of important and unexpected interactions between APOE genotype, LDLR expression, and diet.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 36 条
[1]   Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy [J].
Ballantyne, CM ;
Herd, JA ;
Stein, EA ;
Ferlic, LL ;
Dunn, JK ;
Gotto, AM ;
Marian, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1572-1578
[2]   Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele [J].
Bergeron, N ;
Havel, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :65-72
[3]  
BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[4]  
BOERWINKLE E, 1994, AM J HUM GENET, V54, P341
[5]  
Bohnet K, 1996, J LIPID RES, V37, P1316
[6]  
BRADLEY WA, 1986, J LIPID RES, V27, P40
[7]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[8]   LDL-receptor structure - Calcium cages, acid baths and recycling receptors [J].
Brown, MS ;
Herz, J ;
Goldstein, JL .
NATURE, 1997, 388 (6643) :629-630
[9]  
Cooper AD, 1997, J LIPID RES, V38, P2173
[10]   Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages [J].
Cullen, P ;
Cignarella, A ;
Brennhausen, B ;
Mohr, S ;
Assmann, G ;
von Eckardstein, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1670-1677